Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against <i>Pseudomonas aeruginosa</i>

The inadequate eradication of pulmonary infections and chronic inflammation are significant complications in cystic fibrosis (CF) patients, who usually suffer from persistent and frequent lung infections caused by several pathogens, particularly <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>)....

Celý popis

Podrobná bibliografie

Hlavní autoři:	Nouf M. Alzahrani, Rayan Y. Booq, Ahmad M. Aldossary, Abrar A. Bakr, Fahad A. Almughem, Ahmed J. Alfahad, Wijdan K. Alsharif, Somayah J. Jarallah, Waleed S. Alharbi, Samar A. Alsudir, Essam J. Alyamani, Essam A. Tawfik, Abdullah A. Alshehri
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-04-01
Edice:	Pharmaceutics
Témata:	cystic fibrosis liposomes tobramycin innate defense regulator peptide-1018 (IDR-1018) biofilm <i>Pseudomonas aeruginosa</i>
On-line přístup:	https://www.mdpi.com/1999-4923/14/5/960
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!